Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease
…, C Sandoval‐Castro, CO Vargas‐Serafin… - Arthritis & …, 2015 - Wiley Online Library
Objective Although blood bank–based studies have shown that rheumatoid arthritis (RA)–related
autoantibodies are present before the onset of RA, information on their positive …
autoantibodies are present before the onset of RA, information on their positive …
Sustained clinical remission and rate of relapse after tocilizumab withdrawal in patients with rheumatoid arthritis
…, JD Castillo-Ortiz, C Vargas-Serafin… - The Journal of …, 2013 - jrheum.org
Objective. Data on when to stop use of biological agents in rheumatoid arthritis (RA) are
scant. We assessed the length of remission and the rate of clinical relapse in patients with RA …
scant. We assessed the length of remission and the rate of clinical relapse in patients with RA …
Acute leukemia relapse after hematopoietic stem cell transplantation: the good, the bad, and the ugly of isolated extramedullary relapse in a Latin American population
…, G Pacheco-Gutierrez, C Vargas-Serafín… - … and Cellular Therapy, 2023 - Elsevier
Hematopoietic stem cell transplantation (HSCT) is an effective therapy for acute leukemia (AL).
Relapse represents the main cause of mortality. Isolated extramedullary relapse (iEMR) …
Relapse represents the main cause of mortality. Isolated extramedullary relapse (iEMR) …
Impact of socioeconomic characteristics and comorbidities on therapy initiation and outcomes of newly diagnosed multiple myeloma: real-world data from a resource …
C Vargas-Serafin, AA Acosta-Medina… - … Myeloma and Leukemia, 2021 - Elsevier
Background Outcomes of newly diagnosed multiple myeloma (NDMM) in developing regions
have not paralleled those in developed settings. Economic disadvantage, comorbidities, …
have not paralleled those in developed settings. Economic disadvantage, comorbidities, …
Hematopoietic stem cell transplantation activity for Lymphoma: a Multicentric Study by the transplantation and Cellular Therapy Mexican Working Group
…, GD Leon, C Bourlon De los Rios, CO Vargas-Serafin… - Blood, 2022 - ashpublications.org
Introduction: Despite recent advances in the treatment of Hodgkin and non-Hodgkin lymphoma,
hematopoietic stem cell transplantation (HSCT) remains the cornerstone of therapy for …
hematopoietic stem cell transplantation (HSCT) remains the cornerstone of therapy for …
[HTML][HTML] Role of bone marrow aspirate and biopsy in the diagnosis of hiv patients presenting with low blood counts
S Rajme, C Vargas-Serafin, R Demichelis, C Bourlon - Blood, 2017 - Elsevier
Introduction Patients with HIV infection frequently present with low blood cell counts and need
hematologic approach. Etiology is diverse, being invasive procedures frequently required …
hematologic approach. Etiology is diverse, being invasive procedures frequently required …
Hematopoietic stem cell transplantation activity in Mexico during the COVID19 pandemic: on the way to recovery
…, P Colunga-Pedraza, C Bourlon, C Vargas-Serafín… - …, 2022 - Taylor & Francis
Objective: To analyze the number of HSCTs performed in 2019 vs. 2020 and report the status
of transplant centers (TCs) during and a year after the COVID-19 pandemic. Methods: We …
of transplant centers (TCs) during and a year after the COVID-19 pandemic. Methods: We …
Fluorescent in situ hybridization monitoring and effect of detected early responses in the outcome of patients with chronic phase chronic myeloid leukemia: a report …
…, C Hernandez-Mata, C Vargas-Serafín… - … Myeloma and Leukemia, 2016 - Elsevier
Introduction The cytogenetic hallmark of chronic myeloid leukemia (CML) is the Philadelphia
chromosome. Monitoring the response in patients receiving therapy is a standard of care. …
chromosome. Monitoring the response in patients receiving therapy is a standard of care. …
[PDF][PDF] Transplantation and Cellular Therapy
…, A Soto-Mota, G Pacheco-Gutierrez, C Vargas-Serafín… - 2023 - researchgate.net
Hematopoietic stem cell transplantation (HSCT) is an effective therapy for acute leukemia (AL).
Relapse represents the main cause of mortality. Isolated extramedullary relapse (iEMR) …
Relapse represents the main cause of mortality. Isolated extramedullary relapse (iEMR) …
The number needed to offend: a cross-sectional study of potential offensiveness of rheumatic diagnostic labels
…, AS Russell, P Davis, CO Vargas-Serafin… - Clinical …, 2014 - Springer
This study aims to explore the different connotations and potential offensiveness of ten
mechanistic labels in newly referred Mexican patients with rheumatic symptoms as well as in …
mechanistic labels in newly referred Mexican patients with rheumatic symptoms as well as in …